TSP ADVANCED TECHNOLOGIES PLC

• ⚠

  Material uncertainty over going concern

  The Board of Directors have therefore concluded that they have a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for the foreseeable future, albeit they recognise that there is a material uncertainty in this regard.

1. TSP ADVANCED TECHNOLOGIES PLC 2025-11-04 → present
2. TRUSPINE TECHNOLOGIES PLC 2020-06-05 → 2025-11-04
3. TRUSPINE TECHNOLOGIES LIMITED 2014-12-08 → 2020-06-05

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

PKF Littlejohn LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Board of Directors have therefore concluded that they have a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for the foreseeable future, albeit they recognise that there is a material uncertainty in this regard.”

Group structure

1. TSP ADVANCED TECHNOLOGIES PLC · parent
   1. TruSpine Technologies International Limited 100% · England & Wales · Medical Devices Company developing spinal fusion products
   2. TruSpine Technologies International Inc 100% · America · Medical Devices Company developing spinal fusion products

Significant events

• “The change of name to TSP Advanced Technologies plc was approved, and this will take effect upon registration at Companies House Combined.”
• “The formal adoption of a Bitcoin Treasury Policy, under which the Company may allocate part of its fundraising proceeds into bitcoin as a long-term treasury asset.”
• “Shareholders authorised the expansion of our intellectual property portfolio through targeted acquisitions.”
• “On 23 May 2025, the Company issued 3,300,000 new ordinary shares of 0.01 pence to Axis MedTech (Holdings) Limited ("Axis") at a price of 1.5 pence per share raising gross proceeds of £49,500.”
• “On 15 August 2025 the Company issued a warrant over 2,000,000 new ordinary shares at an exercise price of 20 pence per share, expiring on 31 December 2026 to Proffitt Brothers Investments LLC.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

4

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  -99.5%

  £124,646 → £650

• Net assets

  -16.7%

  £2,549,733 → £2,124,966

• Employees

  —

  Not reported

• Operating profit

  -15.6%

  -£656,406 → -£758,717

• Profit before tax

  -8.3%

  -£701,694 → -£759,948

• Wages

  -60.1%

  £75,205 → £30,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers